menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Innovative Options for Patients with Multiple Myeloma

close
Innovative Options for Patients with Multiple Myeloma
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • In Partnership with

  • Overview

    Multiple myeloma (MM) is an incurable malignancy of plasma cells. Although there have been significant advances in the survival of this condition over the past 15 years, understanding the progression from its precursor state and developing interventions to prevent MM would be significant advances. In this segment, host Dr. Lee Freedman speaks with guest Dr. Brendan Weiss, Assistant Professor of Medicine at the Hospital of the University of Pennsylvania at the Abramson Cancer Center.

Facebook Comments

Recommended
Details
Presenters
Comments
  • In Partnership with

  • Overview

    Multiple myeloma (MM) is an incurable malignancy of plasma cells. Although there have been significant advances in the survival of this condition over the past 15 years, understanding the progression from its precursor state and developing interventions to prevent MM would be significant advances. In this segment, host Dr. Lee Freedman speaks with guest Dr. Brendan Weiss, Assistant Professor of Medicine at the Hospital of the University of Pennsylvania at the Abramson Cancer Center.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 3/4/21